ASX:BGD
ASX:BGDMetals and Mining

3 ASX Penny Stocks With Market Caps Under A$300M To Consider

The Australian sharemarket has rebounded from a brief downturn, closing Week 31’s first day on a positive note with the ASX at around 8,700 points, buoyed by favorable tariff sentiments and a strengthening Aussie dollar. While the term "penny stock" might seem outdated, these smaller or newer companies continue to offer intriguing investment possibilities when backed by solid financials. This article highlights three penny stocks that stand out for their balance sheet strength and potential...
ASX:CIA
ASX:CIAMetals and Mining

ASX Penny Stocks: Botanix Pharmaceuticals And 2 Other Promising Picks

Australian shares are showing resilience as they head into Week 31 with a slight uptick, buoyed by a significant trade deal between the U.S. and European Union that promises to bring stability to global markets. In such an environment, investors often look for stocks that can offer growth potential without excessive risk, which is where penny stocks come into play. Although the term "penny stocks" might seem outdated, these smaller or newer companies continue to present unique opportunities...
ASX:NGI
ASX:NGICapital Markets

3 Undiscovered Gems In Australia With Promising Potential

The Australian stock market recently experienced a mixed performance, with sectors like materials and financials facing declines, while energy and IT showed resilience. In this fluctuating environment, identifying promising small-cap stocks requires keen attention to those with strong fundamentals and growth potential that can thrive despite broader market challenges.
ASX:MAU
ASX:MAUMetals and Mining

Magnetic Resources Joins 2 Other ASX Penny Stocks Worth Watching

The Australian market has experienced a mixed performance recently, with significant declines in materials and financials contrasted by gains in the energy sector. Despite these fluctuations, investors continue to seek opportunities beyond the major players, exploring areas like penny stocks for potential growth. While the term "penny stock" might seem outdated, these smaller or newer companies can still offer surprising value when backed by strong financials and stability.
ASX:TLX
ASX:TLXBiotechs

Telix Pharmaceuticals (ASX:TLX) Is Down 15.9% After Reaffirming 2025 Revenue Outlook and Increased R&D Spend

On July 22, 2025, Telix Pharmaceuticals confirmed its revenue guidance for fiscal year 2025 at A$770 million to A$800 million, driven by ongoing Illuccix sales and 11 months of contributions from its RLS acquisition, while also projecting a 20% to 25% increase in R&D expenditures over the previous year. This reaffirmed outlook highlights Telix's focus on balancing robust commercial operations with sizable investment in future research initiatives. We’ll explore how Telix’s increased R&D...